Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;13(2):111-121.
doi: 10.12997/jla.2024.13.2.111. Epub 2024 Feb 27.

Applicability of Artificial Intelligence in the Field of Clinical Lipidology: A Narrative Review

Affiliations
Review

Applicability of Artificial Intelligence in the Field of Clinical Lipidology: A Narrative Review

Walter Masson et al. J Lipid Atheroscler. 2024 May.

Abstract

The development of advanced technologies in artificial intelligence (AI) has expanded its applications across various fields. Machine learning (ML), a subcategory of AI, enables computers to recognize patterns within extensive datasets. Furthermore, deep learning, a specialized form of ML, processes inputs through neural network architectures inspired by biological processes. The field of clinical lipidology has experienced significant growth over the past few years, and recently, it has begun to intersect with AI. Consequently, the purpose of this narrative review is to examine the applications of AI in clinical lipidology. This review evaluates various publications concerning the diagnosis of familial hypercholesterolemia, estimation of low-density lipoprotein cholesterol (LDL-C) levels, prediction of lipid goal attainment, challenges associated with statin use, and the influence of cardiometabolic and dietary factors on the discordance between apolipoprotein B and LDL-C. Given the concerns surrounding AI techniques, such as ethical dilemmas, opacity, limited reproducibility, and methodological constraints, it is prudent to establish a framework that enables the medical community to accurately interpret and utilize these emerging technological tools.

Keywords: Artificial intelligence; Deep learning; Dyslipidemias; Lipids; Machine learning.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Walter Masson, Pablo Corral, Juan P. Nogueira, Augusto Lavalle-Cobo are editors of Journal of Lipid and Atherosclerosis. However, they were not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1. Concerns and opportunities of using AI techniques in the field of lipidology.
AI, artificial intelligence.

Similar articles

Cited by

References

    1. Parhofer KG. Update lipidology: evidence-based treatment of dyslipidemia. Inn Med (Heidelb) 2023;64:611–621. - PMC - PubMed
    1. Tang L, Li J, Fantus S. Medical artificial intelligence ethics: a systematic review of empirical studies. Digit Health. 2023;9:20552076231186064. - PMC - PubMed
    1. Gomes MA, Kovaleski JL, Pagani RN, da Silva VL, Pasquini TC. Transforming healthcare with big data analytics: technologies, techniques and prospects. J Med Eng Technol. 2023;47:1–11. - PubMed
    1. Hong L, Luo M, Wang R, Lu P, Lu W, Lu L. Big data in health care: applications and challenges. Data Inf Manag. 2018;2:175–197.
    1. Kallapur A, Sallam T. Pharmacotherapy in familial hypercholesterolemia- current state and emerging paradigms. Trends Cardiovasc Med. 2023;33:170–179. - PubMed